Left ventricular assist devices and bleeding: Adding insult to injury

Daniel J. Goldstein, Robert B. Beauford

Research output: Contribution to journalArticle

75 Scopus citations

Abstract

Bleeding is the most common postoperative complication after implantation of left ventricular assist devices, necessitating reoperation in up to 60% of recipients. The implications of massive blood transfusions are great and include infection, pulmonary insufficiency, increased costs, right heart failure, allosensitization, and viral transmission, some of which can prove fatal or preclude transplantation. Preoperative evaluation and preparation are essential, intraoperative hemostasis is imperative, and "shotgun" product replacement should be avoided. Adherence to protocols emphasizing "hemostatic readiness" could reduce the incidence of bleeding complications that pervade left ventricular assist device therapy and potentially improve current successes in bridging to transplantation.

Original languageEnglish (US)
Pages (from-to)S42-S47
JournalAnnals of Thoracic Surgery
Volume75
Issue number6 SUPPL.
DOIs
StatePublished - Jun 1 2003
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Left ventricular assist devices and bleeding: Adding insult to injury'. Together they form a unique fingerprint.

  • Cite this